BUZZ-Valeant Pharmaceuticals: Gets notice of default from bondholders
** Canadian drugmaker's U.S.-listed shares down 2.5 pct at $31.50
** Says got a notice of default from bondholders as a result of a delay filing its annual report
** Centerbridge Partners LP issued the notice, but it is not expected to lead to a default, people familiar with the matter told Reuters
** Valeant said has until June 11 to make the filing, under its bond agreements, but reiterated its intention to file it on or before April 29
** "The noteholders may have just been attempting to protect themselves from any further filing delays," Reorg Research Senior Covenant Analyst Saish Setty says
** Up to Tuesday's close, stock had fallen 68 pct this year
© Thomson Reuters 2017 All rights reserved.